Impact of Peptide Receptor Radionuclide Therapy using Y-90 DOTA-TATE/Lu-177 DOTA-TATE on renal tubular function: Long term follow-up

被引：0
|
作者：
Prasad, V.
Baum, R. P.
机构：
[1] Zent Klin Bad Berka GmbH, Dept Nucl Med, Bad Berka, Germany
[2] Zent Klin Bad Berka GmbH, Ctr PET CT, Bad Berka, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions
    del Olmo-Garcia, Maria I.
    Prado-Wohlwend, Stefan
    Bello, Pilar
    Segura, Angel
    Merino-Torres, Juan F.
    CANCERS, 2022, 14 (03)
  • [42] Treatment of metastasised neuroendocrine tumours with the radiolabeled somatostatin analogues Lu-177 or Y-90-DOTA-TATE: Long term toxicity and survival in 543 patients
    Baum, R. P.
    Prasad, V.
    Hommann, M.
    Zachert, C.
    Hoersch, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S432 - S433
  • [43] Morphologic and metabolic response assessment of 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) with 68Ga-DOTA-TOC PET/CT
    Gaertner, F. C.
    Hillerer, C.
    Lapa, C.
    Miederer, M.
    D'Alessandria, C.
    Wester, H.
    Schwaiger, M.
    Scheidhauer, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S267 - S267
  • [44] Personalized, dosimetry-based PRRT therapy in patients with neuroendocrine tumors using [177Lu]Lu-DOTA-TATE or [177Lu]Lu/[90Y]Y-DOTA-TATE mixture - the initial results of DUONEN multicenter study
    Opalinska, M.
    Kaminski, G.
    Dedecjus, M.
    Kowalska, A.
    Kolodziej, M.
    Saracyn, M.
    Gasior-Perczak, D.
    Lenda-Tracz, W.
    Sowa-Staszczak, A.
    Borkowska, A.
    Budzynska, A.
    Kubik, A.
    Chalewska, W.
    Kacperski, K.
    Szubstarska, P.
    Garnuszek, P.
    Mikolajczak, R.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S314 - S314
  • [45] Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
    Sainz-Esteban, Aurora
    Prasad, Vikas
    Schuchardt, Christiane
    Zachert, Carolin
    Manuel Carril, Jose
    Baum, Richard P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (03) : 501 - 511
  • [46] Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
    D. Magalhães
    I. L. Sampaio
    G. Ferreira
    P. Bogalho
    D. Martins-Branco
    R. Santos
    H. Duarte
    Journal of Endocrinological Investigation, 2019, 42 : 249 - 260
  • [47] Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review
    Magalhaes, D.
    Sampaio, I. L.
    Ferreira, G.
    Bogalho, P.
    Martins-Branco, D.
    Santos, R.
    Duarte, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (03) : 249 - 260
  • [48] Peptide Receptor Radionuclide Therapy using SSTR antagonists: biokinetics and dosimetry of Lu-177 DOTA-LM3
    Schuchardt, C.
    Wiessalla, S.
    Singh, A.
    Zhang, J.
    Kulkarni, H. R.
    Mueller, D.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S90 - S90
  • [49] Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy
    Aurora Sainz-Esteban
    Vikas Prasad
    Christiane Schuchardt
    Carolin Zachert
    José Manuel Carril
    Richard P. Baum
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 501 - 511
  • [50] Peptide receptor radionuclide therapy in radioiodine refractory thyroid cancer: A case report of significant response to lu177 DOTA TATE treatment
    Aghaee, A.
    Nakhaei, S. Ataei
    Aryana, K.
    Mostafavi, S.
    Kosari, H. Mohammadzadeh
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S10 - S11
12345